187 related articles for article (PubMed ID: 8419712)
1. Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations.
Ovrum E; Am Holen E; Abdelnoor M; Oystese R; Ringdal ML
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):78-83. PubMed ID: 8419712
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
5. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial.
Coffey A; Pittmam J; Halbrook H; Fehrenbacher J; Beckman D; Hormuth D
Am Surg; 1995 Jul; 61(7):566-8. PubMed ID: 7793735
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic tranexamic acid decreases bleeding after cardiac operations.
Horrow JC; Hlavacek J; Strong MD; Collier W; Brodsky I; Goldman SM; Goel IP
J Thorac Cardiovasc Surg; 1990 Jan; 99(1):70-4. PubMed ID: 2403616
[TBL] [Abstract][Full Text] [Related]
7. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
[TBL] [Abstract][Full Text] [Related]
8. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery.
Taghaddomi RJ; Mirzaee A; Attar AS; Shirdel A
J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):312-5. PubMed ID: 19103500
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass.
Kochamba GS; Pfeffer TA; Sintek CF; Khonsari S
Ann Thorac Surg; 1996 Mar; 61(3):900-3. PubMed ID: 8619714
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical tranexamic acid in open heart surgery.
Abul-Azm A; Abdullah KM
Eur J Anaesthesiol; 2006 May; 23(5):380-4. PubMed ID: 16438759
[TBL] [Abstract][Full Text] [Related]
12. [The effect of reinfusion of mediastinal blood drained after coronary surgery on coagulation, fibrinolysis and volume of blood products transfused].
Szczerkowski P
Ann Acad Med Stetin; 2003; 49():247-58. PubMed ID: 15552851
[TBL] [Abstract][Full Text] [Related]
13. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting.
Murphy GJ; Mango E; Lucchetti V; Battaglia F; Catapano D; Rogers CA; Angelini GD
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):475-80, 480.e1-8. PubMed ID: 16935098
[TBL] [Abstract][Full Text] [Related]
15. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
[TBL] [Abstract][Full Text] [Related]
16. [Clinical comparative studies on effect of tranexamic acid on blood loss associated with total knee arthroplasty].
Zhang F; Gao Z; Yu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1302-4. PubMed ID: 18277670
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
Lindvall G; Sartipy U; Ivert T; van der Linden J
Ann Thorac Surg; 2008 Jul; 86(1):13-9. PubMed ID: 18573391
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
20. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
